News
-
-
-
-
PRESS RELEASE
Cantourage Group SE // Cantourage Significantly Increases Profitability in the First Quarter of 2026
Cantourage Group SE significantly increases profitability in the first quarter of 2026 driven by premium products and international expansion, with revenue growth and solid financial position -
-
PRESS RELEASE
Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research initiates coverage on Cantourage Group SE with a Buy rating and €11 target price, citing resilience to regulatory challenges and growth potential in the European medical cannabis market -
-
-
-
PRESS RELEASE
Original-Research: Cantourage Group SE (von NuWays AG): BUY
Cantourage Group SE published strong FY25 results, showing 82% yoy growth. Focus on premium strains in Germany, expanding in UK & Poland. FY26e sales to exceed €100m with improved margins. Valuation undemanding. Analyst maintains BUY rating with €10 PT